Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28K Buy
182
+92
+102% +$12.5K ﹤0.01% 723
2025
Q4
$10.2K Hold
90
﹤0.01% 795
2025
Q3
$12K Sell
90
-12
-12% -$1.65K ﹤0.01% 774
2025
Q2
$14.5K Buy
102
+4
+4% +$567 ﹤0.01% 749
2025
Q1
$15K Hold
98
﹤0.01% 730
2024
Q4
$14.7K Hold
98
﹤0.01% 728
2024
Q3
$16.1K Hold
98
﹤0.01% 683
2024
Q2
$13.6K Buy
+98
New +$13.5K ﹤0.01% 694
2021
Q3
Sell
-40
Closed -$5K 503
2021
Q2
$5K Hold
40
﹤0.01% 761
2021
Q1
$4K Buy
+40
New +$4.44K ﹤0.01% 645

Other funds holding DVA

CVA Family Office's DVA Position: Q1 2026 in Review

CVA Family Office increased its DaVita (DVA) stake by 102% in Q1 2026, buying an estimated $12.5K and bringing the position to 182 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #723.

CVA Family Office first reported a position in DVA in Q1 2021 and has held it in 10 quarters since. 582 funds tracked by Wall St. Rank hold DVA as of Q1 2026.

  • CVA Family Office held 182 shares of DaVita worth $28K as of Q1 2026.
  • CVA Family Office bought 92 DaVita shares in Q1 2026, an estimated $12.5K.
  • DaVita made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #723 holding.
  • CVA Family Office first reported a position in DaVita in Q1 2021 and has held it in 10 quarters since.
  • 582 funds tracked by Wall St. Rank held DaVita as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.